Small Cap Biotechs Perk Up On Dealmaking

With M&A picking up we would think smaller deals make sense for large cap biopharma to expand pipelines and complement technology.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.